how to interpret dissolution results for extended release drug product
Published 2 years ago • 4.3K plays • Length 26:08Download video MP4
Download video MP3
Similar videos
-
15:47
dissolution method development for immediate release (ir) drug product
-
12:20
how to interpret dissolution result for ir product as per usp general chapter 711
-
14:51
how to decide the dissolution specification of an ir product?
-
9:15
what next if the dissolution fails at s1, s2, or s3?
-
11:51
what is q in dissolution?
-
31:27
what is method validation? how to perform method validation?
-
22:27
how to determine detection limit (lod) and quantitation limit (loq)
-
3:29
three consecutive batches for validation | why three batches are considered in validation
-
6:41
how to select a dissolution medium for ir product with bcs- i drug substance?
-
12:29
why there is no upper limit for the dissolution?
-
15:10
dissolution profile & f2 calculation
-
11:17
how to prove discriminatory power of a dissolution method?
-
21:57
biopharmaceutics risk assessment to guide dissolution method development for solid oral dosage forms
-
15:23
dissolution method development for generic drugs (24/28) generic drugs forum 2017
-
20:35
what is significant change in the stability study?
-
1:29:37
fip guidelines for dissolution testing of solid oral products
-
20:57
panel on development and validation considerations for drug release and permeation testing
-
8:38
what is a far? when it is used?
-
1:15:01
biorelevant dissolution testing
-
10:21
is the less than lifetime (ltl) limit applies to nitrosamines?
-
16:17
dissolution mechanism and kinetics in the drug development laboratory presented by actera pharma
-
26:07
how to define limit for unknown, known and total impurities